e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Pneumonia and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF)
M. I. Dogrul, N. Bayraktar, S. Akcay (Ankara, Turkey)
Source:
Annual Congress 2013 –Pneumonia and sepsis
Session:
Pneumonia and sepsis
Session type:
Poster Discussion
Number:
303
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. I. Dogrul, N. Bayraktar, S. Akcay (Ankara, Turkey). The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF). Eur Respir J 2013; 42: Suppl. 57, 303
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Procalcitonin (PCT) and C-reactive protein (CRP) as markers of the differential diagnosis of severe community acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Lung function in patients with chronic renal failure (CRF)
Source: Eur Respir J 2004; 24: Suppl. 48, 222s
Year: 2004
Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Inflammatory biomarkers as outcome predictors of acute respiratory failure on top of chronic obstructive pulmonary diseases (COPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Pulmonary hypertension (PH) in chronic hemodialysis (CHD) patients is associated with inflammatory markers and volume overload
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Pulmonary dysfunctions in end stage chronic renal failure (ESCRF) children on regular hemodialysis: possible risk factors
Source: Annual Congress 2007 - Paediatric respiratory physiology in health and disease
Year: 2007
Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept